[Endovascular treatment of SVC syndrome from neoplastic origin: a review of 34 cases].
OBJECTIVE
To report our experience with the treatment of 34 patients with SVC syndrome from neoplastic origin using the Wallstent.


METHODS
Thirty-four patients were treated between January 2000 and February 2007: 21 males and 13 females, aged 44-81 years, with non-small-cell lung carcinoma in 27 cases (79%), small-cell lung carcinoma in 5 cases (15%) and metastatic breast adenocarcinoma to the mediastinum in 2 cases (6%). All patients were treated using the stainless steel self-expanding Wallstent. A dual brachial-femoral access was used in all cases.


RESULTS
Stent placement was possible in all cases. Per procedure acute respiratory distress occurred in 2 cases: 1 case of acute pulmonary edema and 1 case of tamponade. Symptoms resolved within 24 hours. Twenty-six patients died from disease progression, 8 during the first month, and 16 within 32-545 days post-procedure (mean: 213.4 days). Five patients with recurrent SVC syndrome underwent repeat treatment (restenosis in 3 cases, fracture in 1 case, thrombosis in 1 case), for primary and secondary patency rates of 81% and 100%.


CONCLUSIONS
Palliative stent treatment of neoplastic SVC syndrome is reliable, safe and provides long-standing improvement in quality of life.
Da Ines
D
D
Université Clermont 1, UFR Médecine, and Service de Radiologie de l'Hôtel Dieu, CHU Clermont-Ferrand, 63001 Clermont-Ferrand.
Chabrot
P
P
Cassagnes
L
L
Merle
P
P
Filaire
M
M
Ravel
A
A
Garcier
J M
JM
Boyer
L
L
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017130:Angioplasty; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications; D008297:Male; D008479:Mediastinal Neoplasms / Q000150:complications; D008875:Middle Aged; D013479:Superior Vena Cava Syndrome / Q000209:etiology / Q000601:surgery*